Ionis Pharmaceuticals is a leader in RNA-based therapies. Its spinal muscular atrophy drug Spinraza, marketed by partner Biogen, is the first RNA-based therapy to achieve blockbuster status. The ...

The deal grants GSK the rights to develop, manufacture and commercialize two small interfering RNA (siRNA) pipeline products globally, aiming to treat kidney diseases. In exchange, Frontier ...

Messenger RNA (mRNA) technology is transforming medicine by providing our cells with genetic instructions to produce ...

The Irish start-up ecosystem had a busy start to the year, with many announcing significant funding rounds. Chief among the raises is quantum start-up Equal1, which announced a $60m round to help with ...

As non-invasive sample collection continues to expand across diagnostics and clinical research, vaginal self-collection has emerged as a critical approach for applications such as HPV screening, where ...

RIKEN researchers have discovered how an enzyme modifies gene expression by targeting certain stretches of messenger RNA ...

Chemical biomarkers are measurable molecular signatures (host immune markers, pathogen metabolites, volatile organic ...

Eviden has successfully deployed its SkyMon satellite spectrum monitoring solution for the Hellenic Telecommunications and Post Commission, creating the EOS Satellite Monitoring Station dedicated to ...